(Q45632825)

English

Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes

scientific article published in July 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes (English)

1 reference

Europe PubMed Central

14 December 2017

1

1 reference

Europe PubMed Central

14 December 2017

Cecilio Lopez-Galindez

9

1 reference

Europe PubMed Central

14 December 2017

Esteban Domingo Solans

11

1 reference

Europe PubMed Central

14 December 2017

Miguel A Martinez

12

1 reference

Europe PubMed Central

14 December 2017

object named as

Antonio Mas

13

0 references

object named as

Amalia Rubio

6

0 references

author name string

María Pernas

2

1 reference

Europe PubMed Central

14 December 2017

Rafael de la Rosa

3

1 reference

Europe PubMed Central

14 December 2017

Gema Gómez-Mariano

4

1 reference

Europe PubMed Central

14 December 2017

Guerau Fernández

5

1 reference

Europe PubMed Central

14 December 2017

Mariola López

7

1 reference

Europe PubMed Central

14 December 2017

José Miguel Benito

8

1 reference

Europe PubMed Central

14 December 2017

Manuel Leal

10

1 reference

Europe PubMed Central

14 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 July 2004

1 reference

Europe PubMed Central

14 December 2017

Journal of Medical Virology

1 reference

Europe PubMed Central

14 December 2017

73

1 reference

Europe PubMed Central

14 December 2017

3

1 reference

Europe PubMed Central

14 December 2017

350-361

1 reference

Europe PubMed Central

14 December 2017

Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Memory in retroviral quasispecies: experimental evidence and theoretical model for human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Emergence and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Sexual transmission of HIV-1 isolate showing G-->A hypermutation.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team).

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Mutation rates among RNA viruses

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

The natural history and clinical significance of intermittent viraemia in patients with initial viral suppression to < 400 copies/ml

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Chemokines and receptors in HIV encephalitis

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Higher selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1 pol.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

High variability of plasma drug concentrations in dual protease inhibitor regimens

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

DNA deamination mediates innate immunity to retroviral infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Prevalence and predictive value of intermittent viremia with combination hiv therapy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Time to hit HIV, early and hard.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Absence of genetic diversity reduction in the HIV-1 integrated proviral LTR sequence population during successful combination therapy.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Human immunodeficiency viruses and drug therapy: resistance and implications for antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

High rate of recombination throughout the human immunodeficiency virus type 1 genome

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Recombination: Multiply infected spleen cells in HIV patients

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Persistence of HIV-1 resistance in lymph node mononuclear cell RNA despite effective HAART.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Determining the relative efficacy of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Mutagenic outcome of combined antiviral drug treatment during human immunodeficiency virus type 1 replication

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 In vivo mutation rate

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Human immunodeficiency virus type 1 genetic evolution in patients with prolonged suppression of plasma viremia

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Targeting HIV: antiretroviral therapy and development of drug resistance.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Memory in viral quasispecies

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Genotypic testing for human immunodeficiency virus type 1 drug resistance

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Initiation of HAART in drug-naive HIV type 1 patients prevents viral breakthrough for a median period of 35.5 months in 60% of the patients.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Durability of HIV-1 viral suppression over 3.3 years with multi-drug antiretroviral therapy in previously drug-naive individuals

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Recombination in HIV-1

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20098

21 January 2018

Identifiers

10.1002/JMV.20098

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45632825&oldid=2077444905"